Human ESCs are the pluripotent precursor of the three embryonic germ layers. Human ESCs exhibit basal-apical polarity, junctional complexes, integrindependent matrix adhesion, and E-cadherin-dependent cell-cell adhesion, all characteristics shared by the epiblast epithelium of the intact mammalian embryo. After disruption of epithelial structures, programmed cell death is commonly observed. If individualized human ESCs are prevented from reattaching and forming colonies, their viability is significantly reduced. Here, we show that actin-myosin contraction is a critical effector of the cell death response to human ESC dissociation. Inhibition of myosin heavy chain ATPase, downregulation of myosin heavy chain, and downregulation of myosin light chain all increase survival and cloning efficiency of individualized human ESCs. ROCK inhibition decreases phosphorylation of myosin light chain, suggesting that inhibition of actin-myosin contraction is also the mechanism through which ROCK inhibitors increase cloning efficiency of human ESCs.
INTRODUCTION
Embryonic stem cells (ESCs) can proliferate without limit and can differentiate to all cell types of the body (Evans and Kaufman, 1981; Martin, 1981; Thomson et al., 1998) . Although human and mouse ESCs share these basic properties, they are distinct in cell surface markers, morphology, and growth factor requirements. These differences now appear to reflect different embryological origins rather than species specific differences, given that human ESCs more closely resemble pluripotent cell lines derived from the epithelial cells of the mouse epiblast (EpiSC) (Brons et al., 2007; Tesar et al., 2007) . Human ESCs clone at a very poor efficiency under standard culture conditions, probably reflecting their growth in compact, epithelial colonies (Krtolica et al., 2007) . Epithelia are tightly coupled by junctions and are separated from stroma by basement membranes, both of which restrict movements between body compartments. Human ESCs are generally grown on matrices that resemble basement membranes and form colonies with ultrastructural characteristics similar to the epiblast epithelium with tight junctions and apical microvilli (Krtolica et al., 2007; Sathananthan et al., 2002) . Cell-cell junctions between human ESCs also include gap junctions and E-cadherin-mediated cell adhesion (Ullmann et al., 2007; Wong et al., 2004) . Cell-matrix adhesion is necessary for human ESC survival and involves binding through b1 and a integrins (Braam et al., 2008) .
The proliferation and survival of cells in epithelial structures are tightly controlled in vivo, and epithelial cells placed out of their normal environment often die through a process termed anoikis (''homeless''), a specialized form of programmed cell death due to tissue disorganization. Anoikis can result from both caspasedependent and independent pathways (Wang et al., 2003) and is initiated by the disruption of the junctions with the basement membrane and between adjacent epithelial cells (Ellerstrom et al., 2007; Watanabe et al., 2007) . Without drug treatment that blocks specific effectors of anoikis, dissociated epithelial cells die in suspension (Watanabe et al., 2007) . Anoikis is normally prevented by integrin-mediated extracellular matrix signaling and cadherin-mediated cell-cell signaling (Ndozangue-Touriguine et al., 2008; Simpson et al., 2008) . Integrin-and cadherinmediated signaling pathways influence epithelial cell shape, polarization, and survival through interactions with the cytoskeleton, and disruption of these adhesion pathways dramatically alters cytoskeletal architecture.
The actin-myosin based cytoskeleton is a dynamic system essential for contraction, motility, and tissue organization (EvenRam et al., 2007; Ivanov, 2008; Ivanov et al., 2007; Montell, 2008) . Actin-myosin motors consist of actin filaments and nonmuscle myosin II heavy chains (MYHs). Actin filaments are often anchored on integrins and E-cadherins through focal-adhesion and a/b catenin complexes, respectively. The hydrolysis of ATP by the MYH ATPase generates energy and causes the MYHs to slide along actin filaments, resulting in contraction. The process is triggered by the binding of myosin light chain (MLC), which is activated by phosphorylation through kinases, such as Rho-associated kinase (ROCK) or MLC kinase (MLCK) (Quintin et al., 2008) . In order to maintain normal morphology and function, a balance has to be achieved between actinmyosin contraction forces and opposing anchoring forces (Lecuit and Lenne, 2007; Montell, 2008; Okeyo et al., 2009) . If cells are removed from the restraint of their extracellular matrix and cell contacts, the balance is broken and actin-myosin is free to contract, generating altered phenotypes, including excessive membrane blebbing (Fackler and Grosse, 2008; Frey et al., 2006; Ivanov et al., 2005; Sathananthan et al., 2002) . Without re-establishing cell adhesion, the excessive actin-myosin contraction can ultimately result in cell death.
Here, we report that disruption of actin-myosin contraction in individualized human ESC dramatically improves cell survival and cloning efficiency. Blebbistatin is a nonmuscle myosin II heavy chain inhibitor and is named after its ability to specifically inhibit membrane blebbing (Limouze et al., 2004; Straight et al., 2003) . We find that blebbistatin not only represses cell blebbing of human ESCs, but also dramatically improves cell survival and cloning efficiency in defined conditions. Furthermore, we observe that other approaches to disrupting actin-myosin contraction, including downregulation of myosin heavy chain mRNAs or downregulation of myosin light chain, replicate the effects of blebbistatin both on human ESC membrane blebbing and survival. Recently, inhibition of ROCK was shown to regulate cloning efficiency and epithelial structure of human ESCs. We find that actin-myosin contraction is a downstream target of ROCK regulation in cloning and survival. Our combined results demonstrate a central role of actin-myosin contraction in the death of dissociated human ESCs.
RESULTS

Cell-Cell Contact Promotes Human ESC Survival
Most individualized human ESCs die when left in suspension or when plated at clonal cell densities, even when plated on an appropriate matrix that normally supports human ESCs plated in clumps. This cell death could be due to damage associated with cell dissociation or could be due to a lack of cell-cell survival signals. We first sought to examine the time course of cell death and proliferation of individualized human ESCs ( Figure 1A ). Most human ESCs attached to the plate in less than 1 hr and migrated extensively in the first few hours (Movie S1 available online). However, cells started to detach and die at 6 hr. The number of attached cells that remained reached a low point by 12 hr, and after 24 hr, cell numbers stabilized or increased, depending on plating density. When the number of surviving, attached cells over time was plotted as a percentage of the cells initially plated, both initial survival and subsequent increase in cell number were higher for cells plated at higher density (Figure 1A) . We found that cell survival increases with direct cellcell contact ( Figure S1A ), which depends on E-cadherin ( Figure S1B and Movie S1C).
Blebbistatin Inhibits Cell Blebbing after Dissociation
Because human ESCs share an epithelial ultrastructure with the epiblast, and because cell contact is important in human ESC survival, we examined whether cell death of individualized human ESCs shares features of the anoikis observed in other epithelial cell types. Pronounced membrane blebbing, observed after the dissociation of epithelial cells, is an indicator of actinmyosin cytoskeletal contraction and is often a prelude to cell death (Coleman et al., 2001; Croft et al., 2005) . We observed bubble-shaped membrane protrusions on the surface of human ESCs just seconds after cells were individualized ( Figure 1B) . The membrane blebbing was suppressed by blebbistatin, a myosin heavy chain ATPase inhibitor, implicating actin-myosin contraction in human ESC blebbing ( Figure 1B ). We next used Phalloidin to visualize the actin filament organization in dissociated cells. Ring-shaped actin structures, characteristic of blebbing in other cell types, were observed only in untreated cells ( Figure 1B ) and persisted for up to a few hours after plating ( Figure 1C ). Without drug treatment, blebbing was eventually suppressed at the site of cell-cell junctions of those human ESCs that did successfully form clusters after plating and attachment ( Figure S1C ). When blebbistatin was added during human ESC plating, it not only inhibited cell blebbing, but also helped cells attach and spread on the matrigel plates after 3060 min of treatment ( Figure 1C ). Most individualized human ESCs treated with blebbistatin that survived on matrigel for 24 hr formed loose colonies with distinct cell boundaries ( Figure 1D ).
Blebbistatin Increases Cell Survival and Cloning Efficiency of Human ESCs
Membrane blebbing can cause cell death (Croft et al., 2005) , so we examined whether inhibition of membrane blebbing improves human ESC survival. Blebbistatin improved survival of human ESCs examined at 24 hr ( Figure 1E ) and supported an increased cloning efficiency of cells plated at low density and examined for colony formation after 5 days ( Figure 1F ). Time-lapse photography confirmed that blebbistatin facilitated colony formation through the proliferation of a single cell, not by aggregation (Movie S1B). Comparable effects of blebbistatin on cloning efficiency were observed in two human ESC lines (H1 and H9), and two human iPSC lines (iPSimr90C4 and iPSforeskinC6.1) (Yu et al., 2007) (Table S1 ). After blebbistatin treatment, human ESCs were passaged five times and continued to express ESC markers, including OCT4 ( Figure S1D ), maintained normal karyotypes ( Figure S1E ), and formed teratomas. Blebbistatin also helped cell attachment ( Figure S1F ) and improved human ESC survival on tissue culture plates not treated with matrigel. Blebbistatin also helped survival of suspended human ESCs examined at 24 hr (Figures S1G and S1H). Combined, our results suggest that inhibition of myosin function by blebbistatin reduces the requirement for cell-cell and cell-matrix associated signaling in the survival of human ESCs.
MYH9 Is the Major Human ESC Target for Blebbistatin in Survival and Cloning
Blebbistatin is a myosin II heavy chain inhibitor whose binding requires four conserved amino acids in the myosin cleft (Allingham et al., 2005; Limouze et al., 2004) . Because MYH9 and MYH10 are the most highly expressed MYHs with the conserved sites in human ESCs, we first used SMART Pool siRNAs to knock down their mRNAs (Table S2) . Knockdown efficiency and specificity were examined with quantitative RT-PCR (Table S3 and Figure S2A ). Normal morphology and growth were observed after MYH10 siRNA treatment. In a few days, slower cell growth and stretched pseudopods were observed in cells treated with MYH9 siRNA, and the phenotypic changes were most severe when cells were treated with both MYH9 and MYH10 (MYH9/ MYH10) siRNAs (Figure 2A ). Similar to the effect of blebbistatin, the blebbing phenotype was suppressed after dissociation when MYH9 or MYH9/MYH10 was silenced ( Figure 2B ). The silencing of MYH9/MYH10 also led to phenotypic spreading changes after plating, compared with control cells ( Figure 2C ). Knockdown of MYH9 or MYH9/MYH10 improved both initial cell survival ( Figure 2D ) and cloning efficiency ( Figure 2E ). Time-lapse experiments confirmed that colonies were formed from single cells in MYH9 and MYH9/MYH10 siRNA-treated cells. Cells treated with MYH10 siRNA alone behaved comparably to control cells ( Figure 2 ). MYH's role was further confirmed by using individual siRNA duplexes and select siRNAs that employed a different duplex design (Table S2 ; Figures S2B, S2C, and S2H-S2K).
All the results demonstrated that MYH9 silencing inhibited blebbing, and improved cloning efficiency, whereas MYH10 siRNAtreated cells behaved comparably to control cells.
Inhibition of Myosin Light Chain Suppressed Cell Death after Dissociation
MYH-actin contraction is activated through phosphorylated myosin light chain (MLC). We tested whether reduction of MLC levels could also inhibit cell death. We used SMART pool siRNAs to knock down all three MCL family members (MRLC1, MRLC2 and MRLC3) in human ES cells (Table S2 and Figure S2D ). When each gene was individually silenced, membrane blebbing was not repressed and cloning efficiency was not improved ( Figures S3A-B) . However, when all three genes (MRLC1/2/3) were silenced together, cells spread and stretched widely on plate surfaces, exhibiting the same morphology and reduced growth rate as MYH9/MYH10 knockdown cells ( Figure 3A ). Blebbing was inhibited after dissociation ( Figure 3B ), and both initial cell survival and cloning efficiency were improved (Figures 3C and 3D) . These findings were also confirmed with a separate set of siRNAs (Table S2 ; Figures S2E and S3C and S3D), and further support that MYH motors are involved in human ESC blebbing and cell death and that the motors are regulated through MLC.
Actin Disruption Increased Initial Survival and Cloning Efficiency of Dissociated Human ESCs
Cell blebbing involves actin-based protrusions (Figures 1B and 1C) , and myosin motors require intact actin filaments to contract. Here, we tested whether the disruption of actin filaments could prevent myosin-dependent cell death. Among commonly used actin disruption drugs, Cytochalasin D binds to actin barbed ends to prevent actin-filament polymerization, whereas Swinholide A and Mycalolide B sever actin filaments. All three actin inhibitors suppressed membrane blebbing ( Figure 3E ). Twentyfour hours of continuous treatment resulted in significant improvement of cell survival ( Figure 3F ), but no colony formation at low density after 5 days. However, Swinholide A treatment limited to 3 hr after plating improved cloning efficiency, but not as well as blebbistatin ( Figure 3G ). These results are not surprising given that actin is involved in other essential cellular functions besides myosin contraction (Grummt, 2006; Zheng et al., 2009 ). Colonies formed after Swinholide A treatment demonstrated a similar morphology to colonies formed after blebbistatin treatment ( Figure S3E ).
MLC Is a Downstream Target of ROCK Kinase in Human ESCs
ROCK kinases, either directly or indirectly, regulate MLC phosphorylation (Totsukawa et al., 2000) , and it has been shown previously that inhibition of ROCK improves cloning efficiency of human ESCs (Krawetz et al., 2009; Watanabe et al., 2007) . Although the ROCK kinase inhibitor Y27632 is fairly specific, contributory off-target effects of the inhibitor were not excluded, and direct evidence that ROCK is the specific target of the inhibitor for the observed increase in human ESC cloning efficiency has been lacking. Here, we knocked down ROCK1 and ROCK2 separately or together with SMART siRNA pools in human ESCs (Table S2 and Figure S2F ). We found that single knockdown of either ROCK1 or ROCK2 alone did not inhibit blebbing or improve cloning efficiency (Figure 4B and Figure S4A) . However, when both ROCK1 and ROCK2 (ROCK1/ ROCK2) were downregulated, cells stretched more than control cells ( Figure 4A ) and membrane blebbing was suppressed ( Figure 4B ), similar to the phenotype observed in MYH and MLC knockdown cells. ROCK1/ROCK2 siRNA treatment also improved the survival and cloning of individualized human ESCs ( Figures 4C and 4D ). These results were confirmed with a different set of siRNAs against ROCKs (Table S2 ; Figures  S2G and S4B ). Colonies formed after ROCK1/ROCK2 siRNA treatment demonstrated morphology similar to normal human ESCs, with high expression of the pluripotency marker OCT4 ( Figures S3F and S3G ). We further tested whether ROCKs regulate MYH function through MLC phosphorylation. Western blot showed that phosphorylation of MLC (Ser-19) was significantly increased after individualized human ES cells were plated, and that the ROCK inhibitor Y27632 (at 10 mM) suppressed the increased phosphorylation ( Figure 4E ). Similarly, silencing of ROCK1/ROCK2 abolished the increase of MLC phosphorylation ( Figure 4F ). We then performed a dose response curve to examine whether ROCKcontrolled MLC phosphorylation correlated with improved cloning efficiency. With increasing Y27632 concentration, MLC phosphorylation decreased ( Figure 4G ), which correlated with the improvement of cloning efficiency ( Figure 4H ). Similar experiments were performed with another ROCK inhibitor H1152 ( Figures S4C and S4D ). These results further support that ROCKs regulate MYH function through MLC phosphorylation (C) Blebbistatin inhibited blebbing and improved cell spreading 1 hr after plating as visualized by Alexa-staining. (D) Colony morphology of human ESCs 24 hr after splitting and treatment with blebbistatin. (E) The 24 hr survival of individualized human ESCs was significantly improved when 10 mM blebbistatin was added to cells plated at 10,000/cm 2 (*p < 0.05).
Comparable experiments were repeated more than ten times.
(F) Treatment of human ESCs with blebbistatin for 1 hr or longer was sufficient to improve the cloning efficiency (*p < 0.05). Individualized cells were plated in the presence and absence of 10 mM Blebbistatin at a density of 150 cells/cm 2 . Blebbistatin was removed after indicated time points. Cloning efficiency was then calculated after 7 days (*p < 0.05). Comparable time series experiments were repeated two times. In more than 40 single-time point experiments, blebbistatin consistently increased the cloning efficiency of two human ESC lines (H1 and H9) and two iPSC lines (iPS-foreskin and iPS-IMR90) (see Table S1 ). See also Figure S1 , Table S1 , and Movie S1.
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DISCUSSION
Our results suggest that actin-myosin contraction is a major mechanism promoting death of individualized human ESCs. By disrupting the contraction of the actin-myosin motor, either by chemical inhibitors or by siRNA knockdown of individual motor components, cell survival was dramatically improved. Disruption of actin-myosin contraction by these approaches also inhibited membrane blebbing, a phenotype of individualized human ESCs that correlated with cell death. Cell blebbing is caused by unbalanced stresses resulting from the loss of cell anchorage and ultimately can lead to cell death if balance is not restored (Charras et al., 2005) . Individualized human ESCs plated at a high density restored cell-cell contacts, reduced cell blebbing, and survived at a high frequency, even without exogenous inhibition of actin-myosin contraction. It is noteworthy that immediately after plating individual human ESCs, there was extensive cell migration and subsequent cell aggregation into colonies, so colony formation is not a direct measure of cloning efficiency unless low plating densities are used. We found that inhibition of actin-myosin contraction during the initial hour after human ESC dissociation was the critical time period for subsequent survival. For human ESCs plated at Figure S2 and Tables S2 and S3. clonal densities, this initial inhibition of actin-myosin contraction would give some cells time to attach, divide, and re-establish balanced contractile forces and cytoskeletal architecture through cell-matrix and cell-cell adhesion. Because actin-myosin contraction is also involved in the formation of the cleavage furrow and cytokinesis (von Dassow, 2009 
. Knockdown of Myosin Light Chain and Disruption of Actin Filaments Reduce Blebbing and Improve Survival and Cloning Efficiency of Human ESCs
Knockdown (by siRNA) of the three MLC gene products (MRLC1/2/3): (A) changed human ES cell morphology in colonies 96 hr after transfection, (B) decreased blebbing immediately after dissociation, (C) increased (*p < 0.05) cell survival 24 hr after plating, and (D) increased (*p < 0.05) cloning efficiency. Disruption of actin filaments by small molecules: (E) reduced membrane blebbing of human ESCs 2 hr after plating in the presence of Cytochalasin D (100 nM), Swinholide A (10 nM), or Mycalolide B (20 mM), (F) increased human ES cell Survival Index at 24 hr, and (G) increased cloning efficiency after an initial 2 hr treatment with Swinholide A (10 nM). See also Figure S3 and Tables S2 and S3 . See also Figure S4 and Tables S2 and S3 .
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Myosin-Dependent Cell Death in Human ESCs efficiency. We found that exposure to actin inhibitors, including Cytochalasin D, Swinholide A, and Mycalolide B, improved initial human ESC survival, and Swinholide A also improved ESC cloning, but only with limited exposure time, and even then at a lower efficiency than blebbistatin. Actin filaments are a major cytoskeletal component that is involved not only in actin-myosin contraction but also in other diverse functions, ranging from RNA transcription to chromatin remodeling (Zheng et al., 2009 ). Blebbistatin should prevent myosin-actin contraction, but leave other actin functions intact; however, the disruption of actin itself would lead to the disruption of these other essential cellular functions.
It has been previously demonstrated that Rho-ROCK-Myosin signaling axis regulates cell-cell integrity in human ESC colonies (Harb et al., 2008) . Our work shows the important role of this pathway in response to cell dissociation. Our results suggest that disruption of actin-myosin contraction is the mechanism by which ROCK inhibitors increase the cloning efficiency of human ESCs, given that ROCK inhibition reduces the phosphorylation of MLC, an activator of actin-myosin contraction. Interestingly, in contrast to actin and MYH inhibitors, long-term exposure to ROCK inhibitors support both increased initial survival and cloning efficiency of human ESCs. This suggests that reduced MLC phosphorylation is sufficient to block initial cell blebbing and death, but is not sufficient to block cleavage furrow formation and cell division. It is consistent with our result that ROCK inhibition by Y27362 and H1152 did not inhibit all detectable MLC phosphorylation ( Figure 4G and Figure S4C ), and the residual MLC phosphorylation is presumably sufficient to support cytokinesis. It is possible that ROCK is incompletely inhibited, but it is also possible that other kinases are responsible for the observed residual MLC phosphorylation, such as MLCK (Kang et al., 2007; Krawetz et al., 2009) . We found that MLCK inhibitors failed to improve cell survival and cloning efficiency of human ESCs ( Figures S4F-S4I) , and this failure correlated with these inhibitors' inability to suppress blebbing after dissociation ( Figure S4E ). One possible explanation for this difference in response to ROCK and MLCK inhibitors is a spatial compartmentalization of the different phosphorylation events (Totsukawa et al., 2004; Totsukawa et al., 2000) .
Inhibition of actin-myosin contraction increased human ESC survival even in suspension or when cultured on uncoated plates. Unattached human ESCs initially survived well in the presence of blebbistatin, but failed to proliferate, which was not an unexpected result given the effects on cleavage furrow formation and cell division. ROCK inhibition also improved cell survival in suspension (Harb et al., 2008; Watanabe et al., 2007) ; however, long-term growth was poor compared to cells grown on matrigel-coated surfaces. This suggests that the immediate cell death observed in cells deprived of surface contact is probably related to actin-myosin contraction, but that in nonattached conditions additional signals are still needed to promote robust undifferentiated proliferation.
In summary, our results show that the death of individualized human ESCs is executed by actin-myosin contraction, and that inhibition of actin-myosin contraction by several approaches leads to an increased cloning efficiency of both human ESCs and iPSCs. These results provide a model for further studies on the role of cytoskeleton organization in human pluripotent stem cells.
EXPERIMENTAL PROCEDURES
Human ESC Culture Human ESCs were maintained in mTeSR medium on matrigel-coated tissue culture plates . Cells were passaged and analyzed with methods described in the Supplemental Experimental Procedures.
Cloning Assay
Unless specified, all the experiments were done on 12-well plates. Usually triplicates were prepared for each treatment. Prior to the addition of cells, 500 ml media was loaded in each well. Cells were dissociated with TrypLE for 5 min or until fully detached from the plate, neutralized with equal volumes of basic media, counted, washed and diluted to 5000 cells/ml, and finally 100 ml suspension was added into each well. Plates were then placed into 5% O 2 and 10% CO 2 37 C incubator. Small chemical compounds or proteins were added or washed away according to the specified procedure. Media was changed every 1-2 day(s) if not specified. After 5-6 days, colonies were stained with an APS kit as standard procedure (Vector Lab), and counted.
siRNA Knockdown Cells were passaged into mTeSR media one day before the transfection at 5310 5 /well in six-well plates. Media was changed 2 hr before transfection.
Specific siRNA (200 pmol) was mixed with 4 ml Dharmacon siRNA Transfection Reagent 1 as suggested in the standard protocol. For knockdown efficiency by qRT-PCR, RNA was isolated 24 hr after transfection. For survival and cloning experiment, cells were processed for survival and cloning analysis 72-96 hr after transfection. If cell density was too high after transfection, cells were passaged 24 hr after siRNA transfection.
Statistics
In cloning or survival assays, triplicate data were obtained for each condition. A t test was performed so that p values for the difference between the means of the experimental conditions and control could be calculated. Each finding was confirmed by three independent biological replicates, unless specified.
SUPPLEMENTAL INFORMATION
Supplemental Information include three tables, four figures, one movie, and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/j.stem.2010.06.017.
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Cloning Efficiency of human ES cells and iPS cells under blebbistatin treatment
Cell lines Mock experiments Blebbistatin treatments H1 (n>20) <2% ~25% to ~60% H9 (n>6) <2% ~25% to 50% iPS-foreskin (n>10) <2% ~30% to 50% iPS-IMR90 (n>6) <2% ~30% to 60%
See also Figure 1 . fully detached from the plate, neutralized with equal volumes of media, counted, washed, and diluted to 300,000 to 1,000,000 cells/ml, and 100 μl of cells were added into each well. Plates were then placed into 5% O 2 and 10% CO 2 37°C incubator. Small chemical compounds or proteins were added or washed away according to the specified procedure.
Cells were again dissociated at specific time point with 0.4 ml TrypLE, neutralized with equal volumes of 10% FBS in DMEM, harvested with pipettes, and counted by flow cytometry. As an internal control, 5000 count bright beads were added to each sample, and usually ~200 beads were counted for each sample.
Immunostaining and Actin Staining
At each time point, cells were fixed with 4% Paraformaldehyde in PBS with Calcium and Magnesium at room temperature for 5 minutes, neutralized with 0.1M Glycine for 15 minutes at 37 o C, rinsed with PBS, and stored at 4 o C before staining. Cells were permeabilized with 0.5% Triton-X100 PBS and stained with phalloidin. Nucleus was counterstained with DNA dye DAPI.
